Clinical Trial

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Study acronym: ARNOLD
Recruiting
View on ClinicalTrials.gov →
Summary
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-21; most recent amendment 2026-04-15.
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06427304
Lead Sponsor Gérond'if
Conditions Cardiac Amyloidosis
Enrollment 637 participants
Start Date 2024-07-01
Primary Completion 2027-07-02 (estimated)
Study Completion 2028-02-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-20